Literature DB >> 3096462

Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum.

S Tzipori, D Roberton, C Chapman.   

Abstract

A boy aged 6 months who presented with poor weight gain, diarrhoea, and infection with Pneumocystis carinii was found to have congenital hypogammaglobulinaemia, which did not improve despite monthly treatment with intravenous gammaglobulin. At the age of 3 years and 2 months he developed severe vomiting and diarrhoea due to cryptosporidiosis, which failed to respond to conventional treatment. Infusion of hyperimmune bovine colostrum produced against parasite antigen, given by nasogastric tube, was started after symptoms had persisted for three weeks. His vomiting and diarrhoea resolved within five days of treatment, and oocysts were no longer seen in the stools after eight days. Later, however, he developed a rare complication, and oocysts were found in the common bile duct. Hyperimmune bovine colostrum may be useful in the treatment of many patients with immunodeficiency disorders.

Entities:  

Mesh:

Year:  1986        PMID: 3096462      PMCID: PMC1342109          DOI: 10.1136/bmj.293.6557.1276

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  Separation of Cryptosporidium species oocysts from feces by using a percoll discontinuous density gradient.

Authors:  E Waldman; S Tzipori; J R Forsyth
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

Review 2.  Cryptosporidium species a "new" human pathogen.

Authors:  D P Casemore; R L Sands; A Curry
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

3.  Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency.

Authors:  K S Sloper; R R Dourmashkin; R B Bird; G Slavin; A D Webster
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

4.  Cryptosporidial enteritis in a patient with congenital hypogammaglobulinemia.

Authors:  K H Lasser; K J Lewin; F W Ryning
Journal:  Hum Pathol       Date:  1979-03       Impact factor: 3.466

  4 in total
  40 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 2.  Therapeutic potentials of bovine colostrums.

Authors:  B R Thapa
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

Review 3.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

4.  Cryptosporidiosis and acute leukemia.

Authors:  P Heaton
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.

Authors:  J M Bjorneby; B D Hunsaker; M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiency.

Authors:  T L Kuhls; S L Orlicek; D A Mosier; D L Crawford; V L Abrams; R A Greenfield
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Cloning and expression of a cDNA encoding epitopes shared by 15- and 60-kilodalton proteins of Cryptosporidium parvum sporozoites.

Authors:  M C Jenkins; R Fayer; M Tilley; S J Upton
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

9.  Infectivity and neutralization of Cryptosporidium parvum sporozoites.

Authors:  M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

Authors:  P S Doyle; J Crabb; C Petersen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.